Search Results - Dreyling, Martin H.

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Cover Image

    The mTOR inhibitor temsirolimus added to rituximab combined with dexamethasone, cytarabine, and cisplatinum (R-DHAP) for the treatment of patients with relapsed or refractory DLBCL... by Witzens-Harig, Mathias (Author) , Viardot, Andreas (Author) , Keller, Ulrich (Author) , Wosniok, Julia (Author) , Deuster, Oliver (Author) , Klemmer, Jennifer (Author) , Geueke, Anne-Marie (Author) , Meißner, Julia (Author) , Ho, Anthony Dick (Author) , Atta, Johannes (Author) , Marks, Reinhard (Author) , La Rosée, Paul (Author) , Buske, Christian (Author) , Dreyling, Martin H. (Author) , Hess, Georg (Author) ,


    Get full text
    Article (Journal) Online Resource


    Saved in:
  2. 2
    Cover Image

    Rituximab maintenance for the treatment of patients with follicular lymphoma: an updated systematic review and meta-analysis of randomized trials by Vidal, Liat (Author) , Gafter-Gvili, Anat (Author) , Salles, Gilles (Author) , Dreyling, Martin H. (Author) , Ghielmini, Michele (Author) , Hsu Schmitz, Shu-Fang (Author) , Pettengell, Ruth (Author) , Witzens-Harig, Mathias (Author) , Shpilberg, Ofer (Author) ,


    Get full text
    Article (Journal) Online Resource


    Saved in:
  3. 3
    Cover Image

    CDKN2 gene deletion is not found in chronic lymphoid leukaemias of B- and T-cell origin but is frequent in acute lymphoblastic leukaemia by Schröder, Martin (Author) , Mathieu-Strauß, Ulrike (Author) , Dreyling, Martin H. (Author) , Bohlander, Stefan K. (Author) , Hagemeijer, Anne (Author) , Beverloo, Berna H. (Author) , Olopade, Olufunmilayo I. (Author) , Stilgenbauer, Stephan (Author) , Döhner, Konstanze (Author) , Bentz, Martin (Author) , Lichter, Peter (Author) , Döhner, Hartmut (Author) ,


    Get full text
    Article (Journal) Online Resource


    Saved in:

Search Tools: